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Introduction
• Therapeutic radiation is given over multiple treatments 
(fractions), requiring patients to come into the department 
daily.
• Cancer patients are at increased risk of infection and death 
from COVID19 (Liang W. Lancet Oncol 2020).
• We implemented evidence-based COVID19 guidelines on 
3/16/20 to minimize patient exposure risks by avoiding, 
delaying, and shortening patient treatments when possible.
• We analyzed the effectiveness of our COVID guidelines by 
comparing the number of new patient starts and number of 
treatments before and after implementation.
Methods
• Radiation prescriptions at Bodine Cancer Center since 
implementation of COVID19 guidelines were reviewed and 
compared to volume 4 weeks prior.
• Descriptive analysis of number of new prescriptions, number 
of fractions (treatments) per patient, and overall number of 
fractions was performed.
• Data was binned into each week and separated into 
fractionation groups of ≤5, 6-15, and ≥16 fractions per 
prescription.
Conclusion
Our department successfully decreased patient exposure risk by 
reducing new prescription starts, rates of longer treatment 





























































Fig 1. New 
prescriptions per week 
by prescribed number 
of treatments 
(fractionation, fx). 
New starts decreased 
by  ~40%.
Fig 2. Linear 







Fig 3. Total number of 
fractions overall, by 
prescription, and by 
fractionation group.  
Overall number of 
treatments have 
decreased.
